192 related articles for article (PubMed ID: 22968065)
41. Workload and surgeon's specialty for outcome after colorectal cancer surgery.
Archampong D; Borowski D; Wille-Jørgensen P; Iversen LH
Cochrane Database Syst Rev; 2012 Mar; (3):CD005391. PubMed ID: 22419309
[TBL] [Abstract][Full Text] [Related]
42. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
Briganti A; Capitanio U; Chun FK; Gallina A; Suardi N; Salonia A; Da Pozzo LF; Colombo R; Di Girolamo V; Bertini R; Guazzoni G; Karakiewicz PI; Montorsi F; Rigatti P
Eur Urol; 2008 Oct; 54(4):794-802. PubMed ID: 18514383
[TBL] [Abstract][Full Text] [Related]
43. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T
Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166
[TBL] [Abstract][Full Text] [Related]
44. Experience of surgery for rectal cancer with total mesorectal excision in a general surgical practice.
Dowdall JF; Maguire D; McAnena OJ
Br J Surg; 2002 Aug; 89(8):1014-9. PubMed ID: 12153627
[TBL] [Abstract][Full Text] [Related]
45. Results after change of treatment policy for rectal cancer--report from a single hospital in China.
Wu AW; Gu J; Wang J; Ye SW; An Q; Yao YF; Zhan TC
Eur J Surg Oncol; 2007 Aug; 33(6):718-23. PubMed ID: 17240113
[TBL] [Abstract][Full Text] [Related]
46. Treatment of rectal cancer: reduction of local recurrence after the introduction of TME - experience from one University Hospital.
Bernardshaw SV; Øvrebø K; Eide GE; Skarstein A; Røkke O
Dig Surg; 2006; 23(1-2):51-9. PubMed ID: 16717469
[TBL] [Abstract][Full Text] [Related]
47. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial.
den Dulk M; Marijnen CA; Putter H; Rutten HJ; Beets GL; Wiggers T; Nagtegaal ID; van de Velde CJ
Ann Surg; 2007 Jul; 246(1):83-90. PubMed ID: 17592295
[TBL] [Abstract][Full Text] [Related]
48. The features of late local recurrences following curative surgery for rectal cancer.
Uemura M; Ikeda M; Sekimoto M; Noura S; Ohue M; Mizushima T; Yamamoto H; Takemasa I; Yano M; Ishikawa O; Doki Y; Mori M
Hepatogastroenterology; 2012 Sep; 59(118):1800-3. PubMed ID: 23115789
[TBL] [Abstract][Full Text] [Related]
49. Surgeon volume impacts hospital mortality for pancreatic resection.
Eppsteiner RW; Csikesz NG; McPhee JT; Tseng JF; Shah SA
Ann Surg; 2009 Apr; 249(4):635-40. PubMed ID: 19300225
[TBL] [Abstract][Full Text] [Related]
50. Mesorectal grades predict recurrences after curative resection for rectal cancer.
Maslekar S; Sharma A; Macdonald A; Gunn J; Monson JR; Hartley JE
Dis Colon Rectum; 2007 Feb; 50(2):168-75. PubMed ID: 17160574
[TBL] [Abstract][Full Text] [Related]
51. The surgeon as a prognostic factor in the surgical treatment of rectal cancer.
Di Cataldo A; Scilletta B; Latino R; Cocuzza A; Li Destri G
Surg Oncol; 2007 Dec; 16 Suppl 1():S53-6. PubMed ID: 18023175
[TBL] [Abstract][Full Text] [Related]
52. [Long-term result of low anterior resection with stapling devices for rectal cancer].
Pan ZZ; Wan DS; Ding PR; Li LR; Chen G; Wu XJ; Zhou ZW; Lu ZH; Wan XB; Li CM
Ai Zheng; 2004 Nov; 23(11 Suppl):1508-11. PubMed ID: 15566668
[TBL] [Abstract][Full Text] [Related]
53. Management and outcome of local recurrence following transanal endoscopic microsurgery for rectal cancer.
Stipa F; Giaccaglia V; Burza A
Dis Colon Rectum; 2012 Mar; 55(3):262-9. PubMed ID: 22469792
[TBL] [Abstract][Full Text] [Related]
54. Patterns and correlates of patient referral to surgeons for treatment of breast cancer.
Katz SJ; Hofer TP; Hawley S; Lantz PM; Janz NK; Schwartz K; Liu L; Deapen D; Morrow M
J Clin Oncol; 2007 Jan; 25(3):271-6. PubMed ID: 17235044
[TBL] [Abstract][Full Text] [Related]
55. Volume-outcome analysis of colorectal cancer-related outcomes.
Borowski DW; Bradburn DM; Mills SJ; Bharathan B; Wilson RG; Ratcliffe AA; Kelly SB;
Br J Surg; 2010 Sep; 97(9):1416-30. PubMed ID: 20632311
[TBL] [Abstract][Full Text] [Related]
56. Surgical outcomes after total mesorectal excision for rectal cancer.
Chiappa A; Biffi R; Bertani E; Zbar AP; Pace U; Crotti C; Biella F; Viale G; Orecchia R; Pruneri G; Poldi D; Andreoni B
J Surg Oncol; 2006 Sep; 94(3):182-93; discussion 181. PubMed ID: 16900534
[TBL] [Abstract][Full Text] [Related]
57. Effects of surgeon and hospital volume on 5-year survival rates following oral cancer resections: the experience of an Asian country.
Lin CC; Lin HC
Surgery; 2008 Mar; 143(3):343-51. PubMed ID: 18291255
[TBL] [Abstract][Full Text] [Related]
58. Transanal endoscopic microsurgery versus total mesorectal excision of T1 rectal adenocarcinomas with curative intention.
De Graaf EJ; Doornebosch PG; Tollenaar RA; Meershoek-Klein Kranenbarg E; de Boer AC; Bekkering FC; van de Velde CJ
Eur J Surg Oncol; 2009 Dec; 35(12):1280-5. PubMed ID: 19487099
[TBL] [Abstract][Full Text] [Related]
59. Impact of surgeon volume on outcomes of rectal cancer surgery: a systematic review and meta-analysis.
Archampong D; Borowski DW; Dickinson HO
Surgeon; 2010 Dec; 8(6):341-52. PubMed ID: 20950774
[TBL] [Abstract][Full Text] [Related]
60. Does surgeon case volume influence nonfatal adverse outcomes after rectal cancer resection?
Billingsley KG; Morris AM; Green P; Dominitz JA; Matthews B; Dobie SA; Barlow W; Baldwin LM
J Am Coll Surg; 2008 Jun; 206(6):1167-77. PubMed ID: 18501815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
